Titan Medical (TSX:TMD) late last week reported its third quarter financial results, touting the installation of its 1st advanced Sport prototypes and the the company met all its published milestones for the fiscal quarter.
The Toronto-based medical robotics company said it already has two facilities using its Sport platform for preclinical feasibility and validation studies and that it plans to launch additional studies with Columbia University Medical Center and at the European Institut Hospitalo-Universitaire de Strasbourg.
